| NEW CLE PROGRAM | ||||
| Register for the latest CLE from the American Bar Association Health Law Section. | ||||
| Off-label Marketing and Free Speech: Caronia and the Future of Speech in Therapeutic Product Promotion | ||||
| Wednesday, November 12, 2014 | ||||
| 12:00 PM - 1:30 PM Eastern | ||||
| 1.5 CLE Requested | ||||
| Webinar | ||||
The landmark decision in U.S. v. Caronia has emboldened drugs and biologics makers to contest charges of off-label marketing, including the currently pending California False Claims Act case regarding unapproved uses of Integrilin. This webinar will focus on Caronia and other First Amendment cases, including IMS Health Inc. v. Sorrell,evaluating the prosecution of off-label promotion against the therapeutic products industries.The webinar will:
| ||||
2 easy ways to learn more and register
|
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Wednesday, October 8, 2014
Off-label Marketing and Free Speech: Caronia and the Future of Speech in Therapeutic Product Promotion CLE program
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment